EKSO
EKSO BIONICS HOLDINGS, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$15.90
−9.86%Oct 6, 2026, 21:34 UTC
Scott Davis departed as a member of ChronoScale Holdings's board and as chief executive officer of EKSO BIONICS HOLDINGS, INC., receiving a $709,500 lump-sum cash payment and 51,626 restricted stock units.
Oct 2, 2026, 21:34 UTC
Ekso Bionics Chief Operating Officer Jason C. Jones was terminated effective September 30, 2026, with a severance package of $243,750 and up to nine months of COBRA coverage.
Oct 1, 2026, 22:32 UTC
Wandercraft acquired Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation, uniting two robotic mobility companies.
Sep 16, 2026, 21:13 UTC
ChronoScale Holdings Corp amended its Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC, extending the maturity date to November 12, 2026 and designating the sale of guarantor Ekso Bionics, Inc. as a Permitted Disposition.
Aug 18, 2026, 00:00 UTC
ChronoScale Holdings Corp appointed Jerome Wong as Chief Financial Officer, effective August 16, 2026, with an annual base salary of $400,000, a bonus target of 60% of base salary, and a grant of 300,000 restricted stock units vesting over time.
May 4, 2026, 00:00 UTC
Ekso Bionics Holdings, Inc. signed a PIPE investment agreement to issue 1,311,407 shares of its common stock at $12.01 per share to Applied Digital Corporation, raising approximately $15.75 million, with closing conditioned on the effectiveness of its amended articles and the closing of its previously announced business combination.